|
[1]
|
Mempel, T.R., Lill, J.K. and Altenburger, L.M. (2024) How Chemokines Organize the Tumour Microenvironment. Nature Reviews Cancer, 24, 28-50. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Ozga, A.J., Chow, M.T. and Luster, A.D. (2021) Chemokines and the Immune Response to Cancer. Immunity, 54, 859-874. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Chen, K., Bao, Z., Tang, P., Gong, W., Yoshimura, T. and Wang, J.M. (2018) Chemokines in Homeostasis and Diseases. Cellular & Molecular Immunology, 15, 324-334. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Han, W., Lou, Y., Tang, J., Zhang, Y., Chen, Y., Li, Y., et al. (2001) Molecular Cloning and Characterization of Chemokine-Like Factor 1 (CKLF1), a Novel Human Cytokine with Unique Structure and Potential Chemotactic Activity. Biochemical Journal, 357, 127-135. [Google Scholar] [CrossRef]
|
|
[5]
|
Han, W., Ding, P., Xu, M., Wang, L., Rui, M., Shi, S., et al. (2003) Identification of Eight Genes Encoding Chemokine-Like Factor Superfamily Members 1-8 (CKLFSF1-8) by in Silico Cloning and Experimental Validation. Genomics, 81, 609-617. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
韩文玲, 马大龙. 一个新的多功能细胞因子-趋化素样因子附视频[J]. 上海免疫学杂志, 2002, 22(4): 217-219.
|
|
[7]
|
Wang, Y., Zhang, Y., Yang, X., Han, W., Liu, Y., Xu, Q., et al. (2006) Chemokine-Like Factor 1 Is a Functional Ligand for CC Chemokine Receptor 4 (CCR4). Life Sciences, 78, 614-621. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Li, Y., Yu, H. and Feng, J. (2023) Role of Chemokine-Like Factor 1 as an Inflammatory Marker in Diseases. Frontiers in Immunology, 14, Article 1085154. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Yang, G., Chen, X., Sun, Y., Ma, C. and Qian, G. (2013) Chemokine-Like Factor 1 (CLFK1) Is Over-Expressed in Patients with Atopic Dermatitis. International Journal of Biological Sciences, 9, 759-765. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Li, G., Li, G., Wang, Z., Ji, H., Wang, D., Hu, J., et al. (2014) The Chemokine-Like Factor 1 Induces Asthmatic Pathological Change by Activating Nuclear Factor-κB Signaling Pathway. International Immunopharmacology, 20, 81-88. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
李光艳, 宋修云, 胡金凤, 等. CKLF1高表达激活NF-κB信号通路导致小鼠肺部炎症附视频[J]. 中国药理学通报, 2013, 29(10): 1359-1362.
|
|
[12]
|
Hung, C., Wang, K., Liou, Y., Wang, J., Huang, A.Y., Lee, T., et al. (2020) Negative Regulation of the Differentiation of Flk2− CD34− LSK Hematopoietic Stem Cells by EKLF/KLF1. International Journal of Molecular Sciences, 21, Article 8448. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Gnanapragasam, M.N., Planutis, A., Glassberg, J.A. and Bieker, J.J. (2023) Identification of a Genomic DNA Sequence That Quantitatively Modulates KLF1 Transcription Factor Expression in Differentiating Human Hematopoietic Cells. Scientific Reports, 13, Article No. 7589. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Wang, H., Wu, Z. and Xu, K. (2023) CKLF1 Interference Alleviates IL-1β-Induced Inflammation, Apoptosis and Degradation of the Extracellular Matrix in Chondrocytes via CCR5. Experimental and Therapeutic Medicine, 25, Article No. 303. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Ghislat, G., Cheema, A.S., Baudoin, E., Verthuy, C., Ballester, P.J., Crozat, K., et al. (2021) NF-κB-Dependent IRF1 Activation Programs cDC1 Dendritic Cells to Drive Antitumor Immunity. Science Immunology, 6, eabg3570. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Shao, L., Li, T., Mo, X., Majdic, O., Zhang, Y., Seyerl, M., et al. (2010) Expressional and Functional Studies of CKLF1 during Dendritic Cell Maturation. Cellular Immunology, 263, 188-195. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Li, T., Zhong, J., Chen, Y., Qiu, X., Zhang, T., Ma, D., et al. (2006) Expression of Chemokine-Like Factor 1 Is Upregulated during T Lymphocyte Activation. Life Sciences, 79, 519-524. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
钟惟德, 曾广翘, 蔡岳斌, 等. 趋化素样因子-1致不育小鼠睾丸曲细精管的病理改变附视频[J]. 中华实验外科杂志, 2003(11): 68-69, 100.
|
|
[19]
|
王真真, 苑玉和, 韩宁, 等. CKLF1通过激活PLCγ/FAK信号途径促进SH-SY5Y细胞迁移附视频[J]. 中国药理学通报, 2014, 30(9): 1209-1213.
|
|
[20]
|
季迎, 张浩, 袁洪, 等. 趋化素样因子-1在狼疮性肾炎患者肾组织中的表达附视频[J]. 中南大学学报(医学版), 2007(3): 490-493.
|
|
[21]
|
Chen, C., Ai, Q., Tian, H. and Wei, Y. (2024) CKLF1 in Cardiovascular and Cerebrovascular Diseases. International Immunopharmacology, 139, Article ID: 112718. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Zhao, H., Lin, Z., Zhang, P., Rao, J., Xu, S., Luo, Q., et al. (2024) KLF2 Controls the Apoptosis of Neutrophils and Is Associated with Disease Activity of Systemic Lupus Erythematosus. Arthritis Research & Therapy, 26, Article No. 222. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
龚艳君, 洪涛, 蒋捷, 等. 大鼠趋化素样因子2 mRNA在心肌梗死大鼠心脏中的表达附视频[J]. 北京大学学报(医学版), 2003(4): 438-440.
|
|
[24]
|
Wu, J., Li, L., Wu, S. and Xu, B. (2020) CMTM Family Proteins 1-8: Roles in Cancer Biological Processes and Potential Clinical Value. Cancer Biology and Medicine, 17, 528-542. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Wang, L., Wu, C., Zheng, Y., Qiu, X., Wang, L., Fan, H., et al. (2004) Molecular Cloning and Characterization of Chemokine-Like Factor Super Family Member 1 (CKLFSF1), a Novel Human Gene with at Least 23 Alternative Splicing Isoforms in Testis Tissue. The International Journal of Biochemistry & Cell Biology, 36, 1492-1501. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
朱炳梅, 李婷, 周玉玲, 等. 新的潜在的雄激素受体协同抑制因子CMTM1-v17 [J]. 北京大学学报(医学版), 2007, 39(4): 388-393.
|
|
[27]
|
张晓威, 殷华奇, 李清, 等. 人类趋化素样因子超家族2参与小鼠精子形成[J]. 北京大学学报(医学版), 2019, 51(2): 228-233.
|
|
[28]
|
Fujihara, Y., Oji, A., Kojima-Kita, K., Larasati, T. and Ikawa, M. (2018) Co-Expression of Sperm Membrane Proteins CMTM2A and CMTM2B Is Essential for ADAM3 Localization and Male Fertility in Mice. Journal of Cell Science, 131, jcs221481. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
刘振华, 谢京, 萧云备, 等. CMTM2改善环磷酰胺致转基因小鼠模型生殖毒性作用并影响StAR蛋白的表达附视频[J]. 中华男科学杂志, 2013, 19(3): 210-213.
|
|
[30]
|
Song, H., Shi, S., Lu, X., et al. (2010) Intracellular CMTM2 Negatively Regulates Human Immunodeficiency Virus Type-1 Transcription through Targeting the Transcription Factors AP-1 and CREB. Chinese Medical Journal, 123, 2440-2445.
|
|
[31]
|
Hu, F., Sheng, Z., Qin, C., et al. (2016) Research Advances in CKLFSF-Like MARVEL Transmembrane Domain Containing Member 3. Acta Academiae Medicinae Sinicae, 38, 360-363.
|
|
[32]
|
Liu, F., Liu, X., Liu, X., Li, T., Zhu, P., Liu, Z., et al. (2019) Integrated Analyses of Phenotype and Quantitative Proteome of CMTM4 Deficient Mice Reveal Its Association with Male Fertility. Molecular & Cellular Proteomics, 18, 1070-1084. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Plate, M., Li, T., Wang, Y., Mo, X., Zhang, Y., Ma, D., et al. (2010) Identification and Characterization of CMTM4, a Novel Gene with Inhibitory Effects on Hela Cell Growth through Inducing G2/M Phase Accumulation. Molecules and Cells, 29, 355-362. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Li, H., Guo, X., Shao, L., Plate, M., Mo, X., Wang, Y., et al. (2010) CMTM5-v1, a Four-Transmembrane Protein, Presents a Secreted Form Released via a Vesicle-Mediated Secretory Pathway. BMB Reports, 43, 182-187. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Zhang, Y., Wang, J. and Han, W. (2014) A Role for CMTM7 in BCR Expression and Survival in B-1a but Not B-2 Cells. International Immunology, 26, 47-57. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Liu, Z., Liu, Y., Li, T., Wang, P., Mo, X., Lv, P., et al. (2020) CMTM7 Plays Key Roles in TLR-Induced Plasma Cell Differentiation and p38 Activation in Murine B-1 B Cells. European Journal of Immunology, 50, 809-821. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Ge, Y., Duan, H. and Deng, X. (2021) Possible Effects of Chemokine-Like Factor-Like MARVEL Transmembrane Domain-Containing Family on Antiphospholipid Syndrome. Chinese Medical Journal, 134, 1661-1668. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Jin, C., Ding, P., Wang, Y. and Ma, D. (2005) Regulation of EGF Receptor Signaling by the MARVEL Domain-Containing Protein Cklfsf8. FEBS Letters, 579, 6375-6382. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
熊英, 昌晓红, 于黎明. 趋化素样因子-1在卵巢癌中的表达及临床意义附视频[J]. 宁夏医学杂志, 2009, 31(2): 106-108.
|
|
[40]
|
Li, J., Jiang, J.L., Chen, Y.M. and Lu, W.Q. (2023) klf2 Inhibits Colorectal Cancer Progression and Metastasis by Inducing Ferroptosis via the PI3K/Akt Signaling Pathway. The Journal of Pathology: Clinical Research, 9, 423-435. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Wang, J., Zhang, G., Zhang, Y., Luo, Y., Song, Q., Qiu, X., et al. (2014) CMTM1_v17 Is a Novel Potential Therapeutic Target in Breast Cancer. Oncology Reports, 32, 1829-1836. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Song, X., Zhang, S., Tian, R., Zheng, C., Xu, Y., Wang, T., et al. (2021) Expression and Clinical Significance of CMTM1 in Hepatocellular Carcinoma. Open Medicine, 16, 217-223. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Si, J., Zhang, P., Tian, D., Wang, X., Ma, Y., Zhang, J., et al. (2017) CMTM1_v17 Is Associated with Chemotherapy Resistance and Poor Prognosis in Non-Small Cell Lung Cancer. World Journal of Surgical Oncology, 15, Article No. 34. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Hu, F., Yuan, W., Wang, X., Sheng, Z., Yuan, Y., Qin, C., et al. (2015) CMTM3 Is Reduced in Prostate Cancer and Inhibits Migration, Invasion and Growth of LNCaP Cells. Clinical and Translational Oncology, 17, 632-639. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Su, Y., Lin, Y., Zhang, L., Liu, B., Yuan, W., Mo, X., et al. (2014) CMTM3 Inhibits Cell Migration and Invasion and Correlates with Favorable Prognosis in Gastric Cancer. Cancer Science, 105, 26-34. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Zhou, Z., Ma, Z., Li, Z., Zhuang, H., Liu, C., Gong, Y., et al. (2021) CMTM3 Overexpression Predicts Poor Survival and Promotes Proliferation and Migration in Pancreatic Cancer. Journal of Cancer, 12, 5797-5806. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Li, T., Cheng, Y., Wang, P., Wang, W., Hu, F., Mo, X., et al. (2015) CMTM4 Is Frequently Downregulated and Functions as a Tumour Suppressor in Clear Cell Renal Cell Carcinoma. Journal of Experimental & Clinical Cancer Research, 34, Article No. 122. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Zhang, T., Yu, H., Dai, X. and Zhang, X. (2022) CMTM6 and CMTM4 as Two Novel Regulators of PD-L1 Modulate the Tumor Microenvironment. Frontiers in Immunology, 13, Article 971428. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Li, L., Hu, Y., Chen, D., Zhu, J., Bao, W., Xu, X., et al. (2022) CMTM5 Inhibits the Development of Prostate Cancer via the EGFR/PI3K/AKT Signaling Pathway. Molecular Medicine Reports, 25, Article No. 17. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Yuan, Y., Sheng, Z., Liu, Z., Zhang, X., Xiao, Y., Xie, J., et al. (2020) CMTM5-v1 Inhibits Cell Proliferation and Migration by Downregulating Oncogenic EGFR Signaling in Prostate Cancer Cells. Journal of Cancer, 11, 3762-3770. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Li, P., Liu, K., Li, L., Yang, M., Gao, W., Feng, J., et al. (2011) Reduced CMTM5 Expression Correlates with Carcinogenesis in Human Epithelial Ovarian Cancer. International Journal of Gynecological Cancer, 21, 1248-1255. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Zhang, H., Nan, X., Li, X., Chen, Y., Zhang, J., Sun, L., et al. (2014) CMTM5 Exhibits Tumor Suppressor Activity through Promoter Methylation in Oral Squamous Cell Carcinoma. Biochemical and Biophysical Research Communications, 447, 304-310. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Xue, L., Gou, S., Zhang, Y., Yuan, R., Dong, C., Hao, R., et al. (2025) Comprehensive Analysis of CMTM Family and Immune Infiltration in Esophageal Carcinoma. PLOS ONE, 20, e0321037. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Burr, M.L., Sparbier, C.E., Chan, Y., Williamson, J.C., Woods, K., Beavis, P.A., et al. (2017) CMTM6 Maintains the Expression of PD-L1 and Regulates Anti-Tumour Immunity. Nature, 549, 101-105. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Li, H., Li, J., Su, Y., Fan, Y., Guo, X., Li, L., et al. (2014) A Novel 3p22.3 Gene CMTM7 Represses Oncogenic EGFR Signaling and Inhibits Cancer Cell Growth. Oncogene, 33, 3109-3118. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Wu, K., Li, X., Gu, H., Yang, Q., Liu, Y. and Wang, L. (2019) Research Advances in CKLF-Like MARVEL Transmembrane Domain-Containing Family in Non-Small Cell Lung Cancer. International Journal of Biological Sciences, 15, 2576-2583. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Huang, Z., Li, P., Yang, P., Hou, X., Yang, Y., Xu, X., et al. (2019) Overexpression of CMTM7 Inhibits Cell Growth and Migration in Liver Cancer. The Kaohsiung Journal of Medical Sciences, 35, 332-340. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
宣成睿. CKLF1过表达对肾癌细胞增殖、迁移及侵袭能力的影响及机制研究附视频[J]. 南开大学学报(自然科学版), 2023, 56(4): 35-39.
|
|
[59]
|
Zhang, S., Pei, X., Hu, H., Zhang, W., Mo, X., Song, Q., et al. (2016) Functional Characterization of the Tumor Suppressor CMTM8 and Its Association with Prognosis in Bladder Cancer. Tumor Biology, 37, 6217-6225. [Google Scholar] [CrossRef] [PubMed]
|
|
[60]
|
H’ng, C.H., Camp, E., Anderson, P.J., Zannettino, A.C.W. and Gronthos, S. (2020) CMTM8 Is a Suppressor of Human Mesenchymal Stem Cell Osteogenic Differentiation and Promoter of Proliferation via EGFR Signaling. Stem Cells and Development, 29, 823-834. [Google Scholar] [CrossRef] [PubMed]
|
|
[61]
|
Shi, W., Zhang, C., Ning, Z., Hua, Y., Li, Y., Chen, L., et al. (2021) CMTM8 as an LPA1-Associated Partner Mediates Lysophosphatidic Acid-Induced Pancreatic Cancer Metastasis. Annals of Translational Medicine, 9, 42-42. [Google Scholar] [CrossRef] [PubMed]
|